Endocrinology Medical News about Mineralocorticoid receptors

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mineralocorticoid receptors in the metabolic syndrome
Trends in Endocrinology and Metabolism, 10/19/09

Zennaro M–C et al. – This review summarizes the current understanding of MR–mediated effects in diverse tissues and the role of aldosterone as a cardiometabolic risk factor, and discusses the possible relationship between inappropriate MR activation (by both mineralocorticoids and glucocorticoids) and the development of metabolic syndrome.

<< Previous
Varied Presentation of Congenital Adrenal Hyperplasia with 21...

Next >>
Meta-regulation: microRNA regulation of glucose and lipid...

Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction
Hypertension, 11/09/09 Relevance Score: 68%

Mineralocorticoid Receptor Blockers and Chronic Kidney Disease
Clinical Journal of the American Society of Nephrology, 10/08/09 Relevance Score: 65%

Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release
Journal of Psychopharmacology, 10/22/09 Relevance Score: 64%

Evolution, body composition, insulin receptor competition, and insulin resistance
Preventive Medicine, 11/02/09 Relevance Score: 47%

Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain
Neurotherapeutics, 10/05/09 Relevance Score: 47%